Lipid lowering efficacy of atorvastatin

阿托伐他汀 医学 安慰剂 他汀类 荟萃分析 不利影响 胆固醇 内科学 临床试验 血脂 科克伦图书馆 相对风险 随机对照试验 瑞舒伐他汀 置信区间 药理学 替代医学 病理
作者
Stephen P Adams,Michael Tsang,James M Wright
出处
期刊:Cochrane Database of Systematic Reviews [Cochrane]
被引量:114
标识
DOI:10.1002/14651858.cd008226.pub2
摘要

Background Atorvastatin is one of the most widely prescribed drugs and the most widely prescribed statin in the world. It is therefore important to know the dose‐related magnitude of effect of atorvastatin on blood lipids. Objectives To quantify the dose‐related effects of atorvastatin on blood lipids and withdrawals due to adverse effects (WDAE). Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library Issue 4, 2011, MEDLINE (1966 to November 2011), EMBASE (1980 to November 2011), ISI Web of Science (1899 to November 2011) and BIOSIS Previews (1969 to November 2011). No language restrictions were applied. Selection criteria Randomised controlled and uncontrolled before‐and‐after trials evaluating the dose response of different fixed doses of atorvastatin on blood lipids over a duration of 3 to 12 weeks. Data collection and analysis Two review authors independently assessed trial quality and extracted data. WDAE information was collected from the placebo‐controlled trials. Main results Two hundred fifty‐four trials evaluated the dose‐related efficacy of atorvastatin in 33,505 participants. Log dose‐response data revealed linear dose‐related effects on blood total cholesterol, low‐density lipoprotein (LDL)‐cholesterol and triglycerides. Combining all the trials using the generic inverse variance fixed‐effect model for doses of 10 to 80 mg/day resulted in decreases of 36% to 53% for LDL‐cholesterol. There was no significant dose‐related effects of atorvastatin on blood high‐density lipoprotein (HDL)‐cholesterol. WDAE were not statistically different between atorvastatin and placebo for these short‐term trials (risk ratio 0.99; 95% confidence interval 0.68 to 1.45). Authors' conclusions Blood total cholesterol, LDL‐cholesterol and triglyceride lowering effect of atorvastatin was dependent on dose. Log dose‐response data was linear over the commonly prescribed dose range. Manufacturer‐recommended atorvastatin doses of 10 to 80 mg/day resulted in 36% to 53% decreases of LDL‐cholesterol. The review did not provide a good estimate of the incidence of harms associated with atorvastatin because of the short duration of the trials and the lack of reporting of adverse effects in 37% of the placebo‐controlled trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero应助wjx采纳,获得10
1秒前
上官若男应助wjx采纳,获得10
2秒前
希望天下0贩的0应助wjx采纳,获得10
2秒前
wanci应助wjx采纳,获得10
2秒前
赘婿应助wjx采纳,获得10
2秒前
乐乐应助wjx采纳,获得10
2秒前
我是老大应助wjx采纳,获得10
2秒前
Akim应助wjx采纳,获得10
2秒前
Hello应助wjx采纳,获得10
2秒前
领导范儿应助wjx采纳,获得10
2秒前
TANGchenran完成签到,获得积分20
3秒前
情怀应助无奈的白云采纳,获得10
4秒前
4秒前
乖猫要努力应助123456采纳,获得10
5秒前
5秒前
汉堡包应助巡音幻夜采纳,获得10
6秒前
6秒前
dicc发布了新的文献求助10
6秒前
元g发布了新的文献求助10
8秒前
8秒前
陈住气发布了新的文献求助10
9秒前
孙成成发布了新的文献求助10
9秒前
zyq完成签到,获得积分10
10秒前
10秒前
10秒前
友好驳发布了新的文献求助10
11秒前
11秒前
11秒前
13秒前
Sssssss完成签到 ,获得积分10
14秒前
cyy1226发布了新的文献求助10
14秒前
上官若男应助ljw采纳,获得10
16秒前
量子星尘发布了新的文献求助10
16秒前
陈住气完成签到,获得积分20
16秒前
17秒前
ww完成签到,获得积分10
17秒前
17秒前
蓝胖胖蓝完成签到,获得积分10
18秒前
苏航发布了新的文献求助10
20秒前
20秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975458
求助须知:如何正确求助?哪些是违规求助? 3519866
关于积分的说明 11199996
捐赠科研通 3256213
什么是DOI,文献DOI怎么找? 1798133
邀请新用户注册赠送积分活动 877386
科研通“疑难数据库(出版商)”最低求助积分说明 806305